Literature DB >> 6967924

Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice.

M Worthington, M A Conliffe, S Baron.   

Abstract

The role of cellular immunity, humoral antibody, and interferon in recovery from primary systemic infection in mice due to herpes simplex virus type 1 (HSV-1) was studied. Immunosuppression by three methods--each of which was sufficient to suppress humoral and cellular immunity--markedly potentiated primary systemic HSV-1 infection. Immunosuppressed mice did not form neutralizing antibody to HSV-1, but passive transfer of physiologic amounts of neutralizing antibody as late as day 6 after infection exerted a protective effect. Passive transfer of 10(8) immune spleen cells on day 3 after infection was only partially protective and did not thereafter reverse the effect of X-irradiation on HSV-1 infection. Furthermore, mice that received immune cells appeared to make sufficient antibody to explain the protective effect of the transferred cells. These results suggest that antibody to HSV-1 has a critical role in promoting recovery from primary infection in this model. The findings neither favor nor exclude a defensive role for immune cells in this experimental primary HSV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967924     DOI: 10.1093/infdis/142.2.163

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Clinical, pathologic, and immunopathologic characteristics of experimental murine herpes simplex virus stromal keratitis and uveitis is controlled by gene products from the Igh-1 locus on chromosome 12.

Authors:  C S Foster; E M Opremcak; B Rice; P Wells; H Chung; P Thompson; L P Fong; M Raizman
Journal:  Trans Am Ophthalmol Soc       Date:  1987

2.  Murine herpes simplex virus keratitis is accentuated by CD4+, V beta 8.2+ Th2 T cells.

Authors:  C S Foster; A Rodriguez Garcia; M Pedroza-Seres; A Berra; A Heiligenhaus; S Soukiasian; S Jayaraman
Journal:  Trans Am Ophthalmol Soc       Date:  1993

3.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.

Authors:  A Knoblich; J Görtz; V Härle-Grupp; D Falke
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice.

Authors:  L F Kastrukoff; A S Lau; G Y Leung; E E Thomas
Journal:  J Neurol Sci       Date:  1993-07       Impact factor: 3.181

6.  Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.

Authors:  G Palladino; K Mozdzanowska; G Washko; W Gerhard
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

7.  Recovery of mice from herpes simplex virus type 2 hepatitis: adoptive transfer of recovery with immune spleen cells.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

8.  Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.

Authors:  J E Oakes; R N Lausch
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.